Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic

Further Publications Infectiology

Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19

JAMA Intern Med

Panagiotou OA, Kosar CM, White EM, Bantis LE, Yang X, Santostefano CM, Feifer RA, Blackman C, Rudolph JL, Gravenstein S, Mor V

doi: 10.1001/jamainternmed.2020.7968

Viral Infections, Non-HIV

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

Clin Microbiol Infect

Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Giménez E, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Navarro D, Valencian vaccine research program (ProVaVac) study group.

doi: 10.1016/j.cmi.2021.09.031

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Bacterial InfectionsDrug ResistanceRespiratory Tract Infection

Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial

BMJ

Boere TM, van Buul LW, Hopstaken RM, van Tulder MW, Twisk JWMR, Verheij TJM, Hertogh CMPM

doi: 10.1136/bmj.n2198

Viral Infections, Non-HIV

Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Crit Rev Oncol Hematol.

Jafari A, Dadkhahfar S, Perseh S

doi: 10.1016/j.critrevonc.2020.102982.

Viral Infections, Non-HIV

Developing Covid-19 Vaccines at Pandemic Speed

N Engl J Med.

Lurie N, Saville M, Hatchett R, Halton J

doi: 10.1056/NEJMp2005630.

Further Publications AnesthesiologyFurther Publications PainFurther Publications Infectiology

Nursing Education Intervention Effects on Pain Intensity of Nursing Home Residents with Different Levels of Cognitive Impairment: A Cluster-Randomized Controlled Trial

J Pain Res.

Kutschar P, Berger S, Brandauer A, Freywald N, Osterbrink J, Seidenspinner D, Gnass I

doi: 10.2147/JPR.S237056.

Viral Infections, Non-HIV

Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic

J Neurointerv Surg.

Kihira S, Schefflein J, Chung M, Mahmoudi K, Rigney B, Delman BN, Mocco J, Doshi A, Belani P

doi: 10.1136/neurintsurg-2020-016188.

Viral Infections, Non-HIV

Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol

Eur Heart J Acute Cardiovasc Care.

Naksuk N, Lazar S, Peeraphatdit TB

doi: 10.1177/2048872620922784.

Related content

Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial

Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Developing Covid-19 Vaccines at Pandemic Speed

Nursing Education Intervention Effects on Pain Intensity of Nursing Home Residents with Different Levels of Cognitive Impairment: A Cluster-Randomized Controlled Trial

Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic

Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol